|
⚲
|
| Keyboard |
| Michael Dybbs | |
|---|---|
| Firm | Samsara Biocapital LLC |
| Address | 1810 Embarcadero Road Suite 100 Palo Alto, CA 94303 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Samsara Biocapital LLC | |||||
| Samsara Opportunity Fund LP | 021-558824 | Director | 98.0 M of 200.0 M |
270.1 M | |
| Samsara Biocapital LP | 021-283028 | Director | 310.1 M of 310.1 M |
1,900.0 M | |
| Delfi Diagnostics Inc | 021-567314 | Director | 34.3 M of 60.0 M |
||
| Abcuro Inc | 021-538655 | Director | 80.0 M of 200.0 M |
||
| Delfi Diagnostics Inc | 021-453567 | Director | 225.0 M of 225.0 M |
||
| Samsara Biocapital LP | 021-385006 | Director | of 500.0 M |
||
| LEVO Therapeutics Inc | 021-354096 | Director | 46.5 M of 46.5 M |
||
| LEVO Therapeutics Inc | 021-354098 | Director | 40.0 M of 40.0 M |
||
| 565 SPV I LP | 021-352669 | Director | 8.3 M of 8.3 M |
||
| Nkarta Inc | 021-348219 | Director | 43.9 M of 114.6 M |
||
| Sutro Biopharma Inc | 021-314024 | Director | 85.4 M of 85.4 M |
||
| Principia Biopharma Inc | 021-245075 | Director | 15.3 M of 15.3 M |
||
| Versartis Inc | 021-212233 | Director | 55.0 M of 55.0 M |
||
| Versartis Inc | 021-212171 | Director | 10.0 M of 10.0 M |
||
| Versartis Inc | 021-204413 | Director | 10.0 M of 10.0 M |
||
| Versartis Inc | 021-200002 | Director | 12.5 M of 12.5 M |
||